Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹24,536 Cr
P/E Ratio
38.33
P/B Ratio
7.27
Industry P/E
37.25
Debt to Equity
0.13
ROE
21.49 %
ROCE
25.23 %
Div. Yield
0.78 %
Book Value
216.78
EPS
41.21
CFO
₹2,972.34 Cr
EBITDA
₹4,184.48 Cr
Net Profit
₹2,849.73 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
JB Chemicals
| -14.67 | -6.31 | -11.59 | -13.75 | 22.72 | 41.62 | 30.08 |
|
BSE Healthcare
| -7.27 | -1.01 | -0.76 | 19.87 | 19.29 | 22.12 | 9.77 |
|
BSE Mid Cap
| -8.32 | 0.34 | -0.44 | 3.84 | 19.86 | 29.98 | 15.08 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
JB Chemicals
| 14.15 | 67.10 | 9.26 | 72.07 | 136.81 | 36.76 | -9.19 |
|
BSE Mid Cap
| 25.84 | 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 29,705.00 | 63,212.21 | 47.37 | 36.97 | |
| 5,033.50 | 60,209.94 | 27.96 | 19.84 | |
| 311.85 | 37,458.72 | 46.57 | 3.88 | |
| 2,802.70 | 47,502.30 | 55.29 | 49.5 |
No Review & Analysis are available.
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium,... dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. The company provides its services in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India. Read more
Incorporated
1976
Chairman
Arun Duggal
Managing Director
--
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about JB Chemicals & Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of JB Chemicals & Pharmaceuticals Ltd stood at ₹ 4,029 Cr as on 31-Dec-24
The share price of JB Chemicals & Pharmaceuticals Ltd is ₹1,573.70 (NSE) and ₹1,576.05 (BSE) as of 25-Apr-2025 IST. JB Chemicals & Pharmaceuticals Ltd has given a return of 22.72% in the last 3 years.
JB Chemicals & Pharmaceuticals Ltd has a market capitalisation of ₹ 24,536 Cr as on 25-Apr-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of JB Chemicals & Pharmaceuticals Ltd is 7.27 times as on 25-Apr-2025, a 41% premium to its peers’ median range of 5.15 times.
The P/E ratio of JB Chemicals & Pharmaceuticals Ltd is 38.33 times as on 25-Apr-2025, a 3% premium to its peers’ median range of 37.25 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the JB Chemicals & Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of JB Chemicals & Pharmaceuticals Ltd.
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. The company provides its services in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.
The promoter of JB Chemicals & Pharmaceuticals Ltd is TAU INVESTMENT HOLDINGS PTE. LTD.. TAU INVESTMENT HOLDINGS PTE. LTD. owns 47.84 per cent of the total equity. The chairman of the company is Arun Duggal ..
There is no promoter pledging in JB Chemicals & Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
63,212
|
|
|
60,210
|
|
|
47,502
|
|
|
37,459
|
| JB Chemicals & Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
20.86
|
|
Operating margin(%)
|
21.88
|
|
Net Margin(%)
|
16.54
|
|
Dividend yield(%)
|
0.78
|
Yes, TTM profit after tax of JB Chemicals & Pharmaceuticals Ltd was ₹640 Cr.
₹-35.40
(
